Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na V 1.7.

MLA

Rupasinghe, Darshani B., et al. “Mutational Analysis of ProTx-I and the Novel Venom Peptide Pe1b Provide Insight into Residues Responsible for Selective Inhibition of the Analgesic Drug Target Na V 1.7.” Biochemical Pharmacology, vol. 181, Nov. 2020, p. 114080. EBSCOhost, https://doi.org/10.1016/j.bcp.2020.114080.

APA

Rupasinghe, D. B., Herzig, V., Vetter, I., Dekan, Z., Gilchrist, J., Bosmans, F., Alewood, P. F., Lewis, R. J., & King, G. F. (2020). Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na V 1.7. Biochemical Pharmacology, 181, 114080. https://doi.org/10.1016/j.bcp.2020.114080

Chicago

Rupasinghe, Darshani B, Volker Herzig, Irina Vetter, Zoltan Dekan, John Gilchrist, Frank Bosmans, Paul F Alewood, Richard J Lewis, and Glenn F King. 2020. “Mutational Analysis of ProTx-I and the Novel Venom Peptide Pe1b Provide Insight into Residues Responsible for Selective Inhibition of the Analgesic Drug Target Na V 1.7.” Biochemical Pharmacology 181 (November): 114080. doi:10.1016/j.bcp.2020.114080.